261 related articles for article (PubMed ID: 23692413)
1. Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.
Amodio N; Di Martino MT; Neri A; Tagliaferri P; Tassone P
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S125-37. PubMed ID: 23692413
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
3. Role of ncRNA in multiple myeloma.
Leng S; Qu H; Lv X; Liu X
Biomark Med; 2022 Nov; 16(16):1181-1191. PubMed ID: 36688304
[TBL] [Abstract][Full Text] [Related]
4. Emerging pathways as individualized therapeutic target of multiple myeloma.
Misso G; Zappavigna S; Castellano M; De Rosa G; Di Martino MT; Tagliaferri P; Tassone P; Caraglia M
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S95-109. PubMed ID: 23738692
[TBL] [Abstract][Full Text] [Related]
5. Immunologic microenvironment and personalized treatment in multiple myeloma.
Rossi M; Botta C; Correale P; Tassone P; Tagliaferri P
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S83-93. PubMed ID: 23692463
[TBL] [Abstract][Full Text] [Related]
6. Roles of noncoding RNAs in drug resistance in multiple myeloma.
Li J; Zou J; Wan X; Sun C; Chu Z; Hu Y
J Cell Physiol; 2020 Nov; 235(11):7681-7695. PubMed ID: 32324301
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
[TBL] [Abstract][Full Text] [Related]
8. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer.
Wang J; Song YX; Ma B; Wang JJ; Sun JX; Chen XW; Zhao JH; Yang YC; Wang ZN
Int J Mol Sci; 2015 Aug; 16(8):19886-919. PubMed ID: 26307974
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
11. Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma.
Evans RP; Dueck G; Sidhu R; Ghosh S; Toman I; Loree J; Bahlis N; Klimowicz AC; Fung J; Jung M; Lai R; Pilarski LM; Belch AR; Reiman T
Leuk Res; 2011 Dec; 35(12):1637-43. PubMed ID: 21816470
[TBL] [Abstract][Full Text] [Related]
12. [Non-coding RNA in fungi--a review].
Li L; Luo Y; Li S
Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):790-7. PubMed ID: 24341270
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs in endometriosis: a narrative review.
Panir K; Schjenken JE; Robertson SA; Hull ML
Hum Reprod Update; 2018 Jul; 24(4):497-515. PubMed ID: 29697794
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs in prostate cancer: the long and the short of it.
Bolton EM; Tuzova AV; Walsh AL; Lynch T; Perry AS
Clin Cancer Res; 2014 Jan; 20(1):35-43. PubMed ID: 24146262
[TBL] [Abstract][Full Text] [Related]
15. The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A; Hofmeister CC; Pichiorri F
Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
[TBL] [Abstract][Full Text] [Related]
16. Rethinking the central dogma: noncoding RNAs are biologically relevant.
Robinson VL
Urol Oncol; 2009; 27(3):304-6. PubMed ID: 19414118
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs and respiratory disease.
Mestdagh P; Vandesompele J; Brusselle G; Vermaelen K
Thorax; 2015 Apr; 70(4):388-90. PubMed ID: 25378544
[TBL] [Abstract][Full Text] [Related]
18. Panobinostat for the treatment of multiple myeloma.
Neri P; Bahlis NJ; Lonial S
Expert Opin Investig Drugs; 2012 May; 21(5):733-47. PubMed ID: 22404247
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs and cancer: new paradigms in oncology.
Lee SK; Calin GA
Discov Med; 2011 Mar; 11(58):245-54. PubMed ID: 21447283
[TBL] [Abstract][Full Text] [Related]
20. Emerging biological insights and novel treatment strategies in multiple myeloma.
Gentile M; Recchia AG; Mazzone C; Morabito F
Expert Opin Emerg Drugs; 2012 Sep; 17(3):407-38. PubMed ID: 22920042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
